FDA Adverse Event Malfunction Summary report: N

FT4, FREE THYROXINE

MDR report key: 3921872 · Received July 9, 2014

Report

Report Number
1823260-2014-05011
Event Type
Malfunction
Date Received
July 9, 2014
Date of Event
June 13, 2014
Report Date
July 28, 2014
Manufacturer
ROCHE DIAGNOSTICS
Product Code
CEC
PMA / PMN Number
K961489
Removal / Correction Number
NA
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
KS
Reporter Occupation
HEALTH PROFESSIONAL

Narratives

Additional Manufacturer Narrative · 1

A SPECIFIC ROOT CAUSE COULD NOT BE IDENTIFIED AS THE PATIENT SAMPLE WAS NOT AVAILABLE FOR FURTHER INVESTIGATION. BASED ON THE PROVIDED CALIBRATION AND QC DATA, A GENERAL REAGENT ISSUE COULD BE EXCLUDED.

Additional Manufacturer Narrative · 1

THIS EVENT OCCURRED IN (B)(6).

Description of Event or Problem · 1

THE CUSTOMER RECEIVED QUESTIONABLE FREE THYROXINE (FT4) GEN 2 RESULTS FOR ONE PATIENT FROM A COBAS E602 ANALYZER. THE PATIENT IS TESTED ONCE A MONTH FOR FT4. ON (B)(6) 2014, THE RESULT FOR THE PATIENT WAS >7.77 NG/DL. THE USER DILUTED THE SAMPLE AND RECEIVED A RESULT OF 41.5 NG/DL. THE PATIENT WAS HOSPITALIZED ON (B)(6) 2014 DUE TO THE RESULT. ON (B)(6) 2014, THE RESULT FOR A NEW SAMPLE FROM THE PATIENT WAS >7.77 NG/DL. THE USER DILUTED THE SAMPLE AND RECEIVED A RESULT OF 34 NG/DL. ON (B)(6) 2014, THIS SAMPLE WAS TESTED ON AN ABBOTT ARCHITECT ANALYZER AND THE RESULT WAS 4.24 NG/DL. INFORMATION WAS REQUESTED REGARDING IF THE PATIENT WAS ADVERSELY AFFECTED, BUT THIS WAS NOT PROVIDED. PRODUCT LABELING STATES SAMPLES FOR FT4 DETERMINATIONS CANNOT BE DILUTED, AS T4 IN THE BLOOD IS PRESENT IN FREE AND PROTEIN-BOUND FORMS WHICH ARE IN EQUILIBRIUM. A CHANGE IN THE CONCENTRATION OF THE BINDING PROTEINS ALTERS THIS EQUILIBRIUM.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
399400 FT4, FREE THYROXINE RADIOIMMUNOASSAY, FREE THYROXINE CEC ROCHE DIAGNOSTICS NA 17624500

Patients

Seq Age Sex Outcome Treatment
1 053 YR CAMEN TAB| INDENOL TAB